Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies

Pareen Vora, Montse Soriano-Gabarró, Kiliana Suzart, Gunnar Persson Brobert Department of Epidemiology, Bayer Pharma AG, Berlin, Germany Purpose: The risk of venous thromboembolism (VTE) recurrence is high following an initial VTE event, and it persists over time. This recurrence risk d...

Full description

Bibliographic Details
Main Authors: Vora P, Soriano-Gabarró M, Suzart K, Persson Brobert G
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:Patient Preference and Adherence
Subjects:
Online Access:https://www.dovepress.com/limited-evidence-on-persistence-with-anticoagulants-and-its-effect-on--peer-reviewed-article-PPA
_version_ 1818431263064719360
author Vora P
Soriano-Gabarró M
Suzart K
Persson Brobert G
author_facet Vora P
Soriano-Gabarró M
Suzart K
Persson Brobert G
author_sort Vora P
collection DOAJ
description Pareen Vora, Montse Soriano-Gabarró, Kiliana Suzart, Gunnar Persson Brobert Department of Epidemiology, Bayer Pharma AG, Berlin, Germany Purpose: The risk of venous thromboembolism (VTE) recurrence is high following an initial VTE event, and it persists over time. This recurrence risk decreases rapidly after starting with anticoagulation treatment and reduces by ~80%–90% with prolonged anticoagulation. Nonpersistence with anticoagulants could lead to increased risk of VTE recurrence. This systematic review aimed to estimate persistence at 3, 6, and 12 months with anticoagulants in patients with VTE, and to evaluate the risk of VTE recurrence in nonpersistent patients.Methods: PubMed and Embase® were searched up to May 3, 2014 and the search results updated to May 31, 2015. Studies involving patients with VTE aged ≥18 years, treatment with anticoagulants intended for at least 3 months or more, and reporting data for persistence were included. Proportions were transformed using Freeman–Tukey double arcsine transformation and pooled using the DerSimonian–Laird random-effects approach.Results: In total, 12 observational studies (7/12 conference abstracts) were included in the review. All 12 studies either reported or provided data for persistence. The total number of patients meta-analyzed to estimate persistence at 3, 6, and 12 months was 71,969 patients, 58,940 patients, and 68,235 patients, respectively. The estimated persistence for 3, 6, and 12 months of therapy was 83% (95% confidence interval [CI], 78–87; I2=99.3%), 62% (95% CI, 58–66; I2=98.1%), and 31% (95% CI, 22–40; I2=99.8%), respectively. Only two studies reported the risk of VTE recurrence based on nonpersistence – one at 3 months and the other at 12 months.Conclusion: Limited evidence showed that persistence was suboptimal with an estimated 17% patients being nonpersistent with anticoagulants in the crucial first 3 months. Persistence declined over 6 and 12 months. Observational data on persistence with anticoagulation treatment, especially direct oral anticoagulants, in patients with VTE and its effect on risk of VTE recurrence were scarce and further research is required. Keywords: meta-analysis, deep vein thrombosis, recurrence, vitamin K antagonists, direct oral anticoagulants
first_indexed 2024-12-14T15:46:31Z
format Article
id doaj.art-9700ba984ade4a559a37320bec7098a5
institution Directory Open Access Journal
issn 1177-889X
language English
last_indexed 2024-12-14T15:46:31Z
publishDate 2016-08-01
publisher Dove Medical Press
record_format Article
series Patient Preference and Adherence
spelling doaj.art-9700ba984ade4a559a37320bec7098a52022-12-21T22:55:28ZengDove Medical PressPatient Preference and Adherence1177-889X2016-08-01Volume 101657166528649Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studiesVora PSoriano-Gabarró MSuzart KPersson Brobert GPareen Vora, Montse Soriano-Gabarró, Kiliana Suzart, Gunnar Persson Brobert Department of Epidemiology, Bayer Pharma AG, Berlin, Germany Purpose: The risk of venous thromboembolism (VTE) recurrence is high following an initial VTE event, and it persists over time. This recurrence risk decreases rapidly after starting with anticoagulation treatment and reduces by ~80%–90% with prolonged anticoagulation. Nonpersistence with anticoagulants could lead to increased risk of VTE recurrence. This systematic review aimed to estimate persistence at 3, 6, and 12 months with anticoagulants in patients with VTE, and to evaluate the risk of VTE recurrence in nonpersistent patients.Methods: PubMed and Embase® were searched up to May 3, 2014 and the search results updated to May 31, 2015. Studies involving patients with VTE aged ≥18 years, treatment with anticoagulants intended for at least 3 months or more, and reporting data for persistence were included. Proportions were transformed using Freeman–Tukey double arcsine transformation and pooled using the DerSimonian–Laird random-effects approach.Results: In total, 12 observational studies (7/12 conference abstracts) were included in the review. All 12 studies either reported or provided data for persistence. The total number of patients meta-analyzed to estimate persistence at 3, 6, and 12 months was 71,969 patients, 58,940 patients, and 68,235 patients, respectively. The estimated persistence for 3, 6, and 12 months of therapy was 83% (95% confidence interval [CI], 78–87; I2=99.3%), 62% (95% CI, 58–66; I2=98.1%), and 31% (95% CI, 22–40; I2=99.8%), respectively. Only two studies reported the risk of VTE recurrence based on nonpersistence – one at 3 months and the other at 12 months.Conclusion: Limited evidence showed that persistence was suboptimal with an estimated 17% patients being nonpersistent with anticoagulants in the crucial first 3 months. Persistence declined over 6 and 12 months. Observational data on persistence with anticoagulation treatment, especially direct oral anticoagulants, in patients with VTE and its effect on risk of VTE recurrence were scarce and further research is required. Keywords: meta-analysis, deep vein thrombosis, recurrence, vitamin K antagonists, direct oral anticoagulantshttps://www.dovepress.com/limited-evidence-on-persistence-with-anticoagulants-and-its-effect-on--peer-reviewed-article-PPAmedication persistencesystematic reviewvenous thromboembolismvitamin k antagonistsdirect oral anticoagulants.
spellingShingle Vora P
Soriano-Gabarró M
Suzart K
Persson Brobert G
Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
Patient Preference and Adherence
medication persistence
systematic review
venous thromboembolism
vitamin k antagonists
direct oral anticoagulants.
title Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
title_full Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
title_fullStr Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
title_full_unstemmed Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
title_short Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies
title_sort limited evidence on persistence with anticoagulants and its effect on the risk of recurrence of venous thromboembolism a systematic review of observational studies
topic medication persistence
systematic review
venous thromboembolism
vitamin k antagonists
direct oral anticoagulants.
url https://www.dovepress.com/limited-evidence-on-persistence-with-anticoagulants-and-its-effect-on--peer-reviewed-article-PPA
work_keys_str_mv AT vorap limitedevidenceonpersistencewithanticoagulantsanditseffectontheriskofrecurrenceofvenousthromboembolismasystematicreviewofobservationalstudies
AT sorianogabarrom limitedevidenceonpersistencewithanticoagulantsanditseffectontheriskofrecurrenceofvenousthromboembolismasystematicreviewofobservationalstudies
AT suzartk limitedevidenceonpersistencewithanticoagulantsanditseffectontheriskofrecurrenceofvenousthromboembolismasystematicreviewofobservationalstudies
AT perssonbrobertg limitedevidenceonpersistencewithanticoagulantsanditseffectontheriskofrecurrenceofvenousthromboembolismasystematicreviewofobservationalstudies